167 related articles for article (PubMed ID: 37742793)
1. Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial.
Zeng X; Zhu J; Li J; Chen C; Sang L; Liu M; Song L; Liu H
J Pain Symptom Manage; 2024 Jan; 67(1):50-58. PubMed ID: 37742793
[TBL] [Abstract][Full Text] [Related]
2. Hydromorphone for cancer pain.
Li Y; Ma J; Lu G; Dou Z; Knaggs R; Xia J; Zhao S; Dong S; Yang L
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011108. PubMed ID: 34350974
[TBL] [Abstract][Full Text] [Related]
3. Hydromorphone for cancer pain.
Bao YJ; Hou W; Kong XY; Yang L; Xia J; Hua BJ; Knaggs R
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011108. PubMed ID: 27727452
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
5. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Wirz S; Wartenberg HC; Nadstawek J
Support Care Cancer; 2008 Sep; 16(9):999-1009. PubMed ID: 18095008
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial.
Ma K; Jin Y; Wang L; Feng ZY; Song T; Yang XQ; Chen FQ; Duan BL; Huang YQ; Xie GL; Bao HG; Wang K; Xu JT; Lu Y; Liu YQ
Pain; 2020 Nov; 161(11):2502-2510. PubMed ID: 32569090
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.
Lin R; Zhu J; Luo Y; Lv X; Lu M; Chen H; Zou H; Zhang Z; Lin S; Wu M; Li X; Zhou M; Zhao S; Su L; Liu J; Huang C
J Natl Compr Canc Netw; 2022 Sep; 20(9):1013-1021.e3. PubMed ID: 36075387
[TBL] [Abstract][Full Text] [Related]
8. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
9. Patient-Controlled Subcutaneous Analgesia with Hydromorphone versus Oral Oxycontin for Opioid Titration of Cancer Pain: A Prospective Multicenter Randomized Trial.
Xiao X; Sun J; Zhang D; Li L; Zhou H; Li Y; Li Q; He Z; Fu Y; Duan Q; Zheng G; Tang Z; Chu Q; Chen Y
J Pain Res; 2024; 17():1441-1451. PubMed ID: 38628430
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
11. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
[TBL] [Abstract][Full Text] [Related]
12. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial.
Beaudoin FL; Lin C; Guan W; Merchant RC
Acad Emerg Med; 2014 Nov; 21(11):1193-202. PubMed ID: 25377395
[TBL] [Abstract][Full Text] [Related]
13. The side effects of morphine and hydromorphone patient-controlled analgesia.
Hong D; Flood P; Diaz G
Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
15. Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
Yang Y; Wu J; Li H; Ye S; Xu X; Cheng L; Zhu L; Peng Z; Feng Z
BMC Anesthesiol; 2018 Apr; 18(1):37. PubMed ID: 29636011
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydromorphone and morphine intravenous analgesia on plasma motilin and postoperative nausea and vomiting in patients undergoing total hysterectomy.
Liu Y; Yang L; Tao SJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5697-5703. PubMed ID: 30229847
[TBL] [Abstract][Full Text] [Related]
17. Patient-Controlled Analgesia After Cardiac Surgery With Median Sternotomy: No Advantages of Hydromorphone When Compared to Morphine.
Wehrfritz A; Senger AS; Just P; Albart M; Münchsmeier M; Ihmsen H; Schüttler J; Jeleazcov C
J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3587-3595. PubMed ID: 35662486
[TBL] [Abstract][Full Text] [Related]
18. Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.
Lin R; Lin S; Feng S; Wu Q; Fu J; Wang F; Li H; Li X; Zhang G; Yao Y; Xin M; Lai T; Lv X; Chen Y; Yang S; Lin Y; Hong L; Cai Z; Wang J; Lin G; Lin S; Zhao S; Zhu J; Huang C
J Natl Compr Canc Netw; 2021 Aug; 19(10):1148-1155. PubMed ID: 34343968
[TBL] [Abstract][Full Text] [Related]
19. Hydromorphone versus morphine: a historical cohort study to evaluate the quality of postoperative analgesia.
Rodrigues S; Shin D; Conway M; Smulski S; Trenker E; Shanthanna H; Vanniyasingam T; Thabane L; Paul J
Can J Anaesth; 2021 Feb; 68(2):226-234. PubMed ID: 33170454
[TBL] [Abstract][Full Text] [Related]
20. Patient-controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III-IV cancer: A multi-center randomized controlled clinical trial.
Wan CF; Meng QZ; Wang YW; Qi L; Ai CL; Sui X; Song T
Cancer Med; 2020 Aug; 9(15):5345-5352. PubMed ID: 32500675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
